Home/Lucid Diagnostics/Alfred J. Novak
AJ

Alfred J. Novak

Director

Lucid Diagnostics

Therapeutic Areas

Lucid Diagnostics Pipeline

DrugIndicationPhase
EsoCheck® / EsoGuard® SystemDetection of Barrett's Esophagus and associated dysplasia in at-risk patients (e.g., chronic GERD)Commercial